EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death and lacks effective treatment options. Diagnostic endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) biopsies represent an appealing source of material for molecular analysis to inform targeted therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundy, Joanne, Harris, Marion, Zalcberg, John, Zimet, Allan, Goldstein, David, Gebski, Val, Borsaru, Adina, Desmond, Christopher, Swan, Michael, Jenkins, Brendan J., Croagh, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696205/
https://www.ncbi.nlm.nih.gov/pubmed/34956889
http://dx.doi.org/10.3389/fonc.2021.770022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696205/
https://www.ncbi.nlm.nih.gov/pubmed/34956889
http://dx.doi.org/10.3389/fonc.2021.770022

Ejemplares similares